Name: RxSight, Inc. (RXST) Financial Statements
Creator: FinSpry

RxSight Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

RxSight, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	139.93	89.08	49.01	22.59	14.68
Cost of Revenue	40.98	35.31	27.68	18.08	12.97
Gross Profit	98.94	53.77	21.33	4.52	1.71
Operating Expenses
Research & Development	34.37	29.05	25.98	24.20	21.75
Selling, General & Administrative	101.43	74.80	58.67	33.10	15.36
Operating Expenses	135.80	103.85	84.65	57.30	37.11
Operating Income	-36.86	-50.09	-63.32	-52.79	-35.41
Other Income/Expense
Interest Income	9.47	6.57	1.52	0.05	0.54
Interest Expense	0.02	3.31	4.95	-3.68	-0.51
Other Income/Expense	9.45	-1.77	-0.08	7.74	63.01
Income
Income Before Tax	-27.41	-48.59	-66.75	-48.68	27.63
Income Tax Expense	0.05	0.02	0.01	0.01	0.06
Net Income	-27.46	-48.61	-66.76	-48.69	27.58
Net Income - Continuous Operations	-27.46	-48.61	-66.76	-48.69	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-23.76	-41.04	-57.78	-48.81	-31.55
EBIT	-27.38	-45.28	-61.80	-52.79	-35.41
Depreciation & Amortization	3.62	4.24	4.02	3.98	3.85
Earnings Per Share
Basic EPS	-1.00	-1.00	-2.00	-4.00	1.00
Diluted EPS	-1.00	-1.00	-2.00	-4.00	-
Basic Shares Outstanding	38.87	34.46	27.66	13.63	3.71
Diluted Shares Outstanding	38.87	34.46	27.66	13.63	5.53